study for the clinician to decide on bone marrow examinatio
Phase 4
Completed
- Registration Number
- CTRI/2018/03/012407
- Lead Sponsor
- Patient
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. All cases of thrombocytopenia with platelet count below 1,50,000/cu mm with or without bone marrow studies.
2. The cases with sufficient clinico-haematological work up with established clinical diagnosis will be included.
3. Only one sample of the single participant will be taken.
Exclusion Criteria
1. Pseudothrombocytopenia
2. Patients who have received blood transfusion or platelet transfusion within 7 days
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The cases will be broadly classified into two groups on the basis of cause of thrombocytopenia- due to peripheral hyperdestruction(immune thrombocytopenic purpura; infection like malaria, dengue; drug induced, etc.) and hypoproliferative bone marrow (megaloblastic anaemia; leukaemia; aplastic anaemia; myelodysplastic syndrome; myelofibrosis; multiple myeloma; marrow infilteration).Timepoint: 30th April 2018
- Secondary Outcome Measures
Name Time Method Research still going onTimepoint: 31st July 2018